HR Execs on the Move

Aspenti Health

www.aspenti.com

 
Built by science, driven by compassion. Aspenti Health is an innovative, comprehensive clinical drug testing lab that is seeking to redefine the role of the traditional healthcare testing partners. Led by experienced healthcare professionals, we are focused on shaping a future in which we are instrumental in helping our patients meet their recovery goals. We also are investing in our social mission to create lasting and effective impact through community involvement. We believe in improving patient outcomes through enhanced treatment access and patient advocacy. Unlike other testing partners, Aspenti works hand in hand with our care providers in order to ...
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.aspenti.com
  • 199 Main Street Suite 226
    Burlington, VT USA 05401
  • Phone: 802.863.4105

Executives

Name Title Contact Details

Similar Companies

Inteleso

Inteleso is a Orlando, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SSM Health Care System Inc.

Sponsored by the Franciscan Sisters of Mary and based in St. Louis, Mo., SSM Health Care (SSMHC) is one of the largest Catholic systems in the country.

Granite MEDSystems Americas

Granite MEDSystems Americas is a Mequon, WI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Cellanyx

Cellanyx has developed proprietary live tumor cell phenotypic biomarker tests to improve cancer risk-stratification and allow informed clinical decision making. The Companys unique approach provides quantitative and actionable information based on analysis of thousands of live tumor cells. The Companys tests employ a microfluidic platform combined with machine vision and machine learning approaches to analyze phenotypic morphological, biochemical and biophysical markers. Cellanyx has demonstrated initial clinical proof-of-concept with its lead phenotypic test in prostate cancer. The initial clinical proof-of-concept study was conducted to demonstrate improved risk stratification in men with low and intermediate Gleason grade (6 and 7) disease and reduce the number of repeat biopsies. Furthermore, analysis of field samples (away from the suspicious core) demonstrated the potential value of Cellanyx phenotypic test as it was able to analyze the tumor microenvironment conditions and predict expected adverse pathology from samples that were not taken from the suspicious core. These new findings from the Cellanyx prostate test are transformative as it will reduce the errors in diagnosing cancers early due to sampling heterogeneity of prostate biopsies.

Ameri-Pac Inc

Ameri-Pac, Inc. is a manufacturer of animal health and nutrition specialty products for the pet food, companion animal, farm animal, veterinary and aquaculture industries. We are a family-owned business with three generations involved in the day-to-day